Loading…

APEX - Owned by Aridis Pharmaceuticals Inc. - (Class 042) | Sealvo

Home Search: APEXAPEX #88809371

Updated Sep 27, 2026·11 searches this week

View on USPTO TSDR Find similar marks

APE

USPTO Trademark Record

ABANDONED

APEX

SN 88809371·Reg 0·Filed Feb 25, 2020

Owner Aridis Pharmaceuticals Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

APEX (Serial No. 88809371), Registration No. 0, is a abandoned US trademark filed on Feb 25, 2020 by Aridis Pharmaceuticals Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Conflict Analysis

Full conflict analysis for APEX (SN 88809371) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

APEX (Reg. #0) is an abandoned US trademark that was filed in 2020 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research....

FILED

Feb 25, 2020

SERIAL

88809371

REG#

0

REGISTERED

Dec 31, 1969

Filing Information

StatusABANDONED

Filing DateFeb 25, 2020

Serial Number88809371

Registration No.0

Registration DateDec 31, 1969

Status DateNov 30, 2020

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application Currently

Full Goods & Services

CLASSES

1

OFFICE

USPTO

COUNTRY

US

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jan 24, 2020

First use in commerce: Jan 24, 2020

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

8 events

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Nov 30, 2020

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Nov 30, 2020

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

NON-FINAL ACTION WRITTEN

May 19, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 19, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 19, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

May 14, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Feb 28, 2020

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 28, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by Aridis Pharmaceuticals Inc.

Additional USPTO filings from the same owner.

PANAECIN

86652619

Aridis Pharmaceuticals Inc.

YPEX

90234587

Aridis Pharmaceuticals Inc.

SALVECIN

86652719

Aridis Pharmaceuticals Inc.

BREATH CHO

88809405

Aridis Pharmaceuticals Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

APEX

88239789

Apex Systems, LLC

APEX

88091199

Apex Software Technologies, LLC

APEX

86147031

American Society for Radiation Oncology

APEX

87666980

Apex Brands, Inc.